The biggest buzz around GLP-1 drugs these days has nothing to do with weight loss. And that might lead to some problems for ...

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Compared with other antidiabetic drugs, semaglutide is associated with a lower risk for Alzheimer disease-related dementia in patients with type 2 diabetes.

Lifestyle interventions can slow cognitive decline in your 60s and 70s, according to a large randomized controlled trial.

A cancer drug that has already been approved by the US Food and Drug Administration (FDA) could also help people with ...